SCHEMBL4650969

SCHEMBL4650969

CC(C)(C)c1[c]c2c(cc1)-c1ccc(C(C)(C)C)cc1C2.[LiH]

nearest known ligand 0.34

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.34
NPC1 O15118 1/20 0.34
PLA2G1B P04054 1/20 0.34
NFKB1 P19838 1/20 0.34
CASP3 P42574 1/20 0.34
RAB9A P51151 1/20 0.34
NFKB2 Q00653 1/20 0.34
RELA Q04206 1/20 0.34
SENP8 Q96LD8 1/20 0.34
SENP7 Q9BQF6 1/20 0.34
SENP6 Q9GZR1 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
ATG4B Q9Y4P1 1/20 0.34
HPGD P15428 1/20 0.32
ALOX15 P16050 1/20 0.32
HSD17B10 Q99714 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
CYP1A2 P05177 1/20 0.30
CYP2C19 P33261 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL714734 0.98 ALDH1A1 (0.35) ALDH1A1NPC1PLA2G1BNFKB1CASP3
SCHEMBL6552336 0.80 ALDH1A1 (0.44) ALDH1A1NPC1PLA2G1BNFKB1CASP3
Lithium SCHEMBL6552341 0.80 ALDH1A1 (0.44) ALDH1A1NPC1PLA2G1BNFKB1CASP3
SCHEMBL40372 0.78 ALDH1A1 (0.45) ALDH1A1NPC1PLA2G1BNFKB1CASP3
SCHEMBL29459210 0.78 ALDH1A1 (0.45) ALDH1A1NPC1PLA2G1BNFKB1CASP3
SCHEMBL6142471 0.78 POLB (0.31)
SCHEMBL1029280 0.78 ALDH1A1 (0.38) ALDH1A1NPC1RAB9AHPGDHSD17B10
SCHEMBL7609399 0.77 NPC1 (0.32) ALDH1A1NPC1PLA2G1BNFKB1CASP3
SCHEMBL8858623 0.76 ALDH1A1 (0.40) ALDH1A1NPC1PLA2G1BNFKB1CASP3
Hydrochloric Acid SCHEMBL28338025 0.75 ALDH1A1 (0.42) ALDH1A1NPC1PLA2G1BNFKB1CASP3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1768990-B1 IMPROVED SYNTHESIS OF ANSA-METALLOCENES AND THEIR PARENT LIGANDS IN HIGH YIELD CHEVRON PHILLIPS CHEMICAL CO (US) 2008-10-01 EP disclosed
EP-1768990-A1 IMPROVED SYNTHESIS OF ANSA-METALLOCENE AND THEIR PARENT LIGANDS IN HIGH YIELD Chevron Phillips Chemical Company LP (US) 2007-04-04 EP disclosed
US-7064225-B2 Synthesis of ansa-metallocenes and their parent ligands in high yield CHEVRON PHILLIPS CHEMICAL COMPANY, L.P. (US) 2006-06-20 US disclosed
WO-2006012315-A1 IMPROVED SYNTHESIS OF ANSA-METALLOCENE AND THEIR PARENT LIGANDS IN HIGH YIELD CHEVRON PHILLIPS CHEMICAL COMPANY, LP (US) 2006-02-02 WO disclosed
US-20050285284-A1 Synthesis of ansa-metallocenes and their parent ligands in high yield CHEVRON PHILLIPS CHEMICAL COMPANY 2005-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050285284-A1 Synthesis of ansa-metallocenes and their parent ligands in high yield TERT, ARSA, MNS1 ALDH1A1 371/4885NPC1 2404/4885PLA2G1B 4572/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.